Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Somanjali Das

JM Financial calls Metropolis Healthcare ‘best-value diagnostic stock’, sees up to 27% upside

JM Financial has maintained its Buy rating on Metropolis Healthcare (MHL) with a 12-month target price of Rs 734, implying an upside of 27.2% from the current market price of Rs 577.

The rating and target remain unchanged from the brokerage's previous estimate, following an analyst meeting on August 27.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.